EANO Meeting 2018

SCIENTIFIC PROGRAMME

Room: tbc

 

19:30 – 21:30

Special Lecture & Get together

 

Chair: Roger Henriksson, Stockholm/SE

 

 

Room: tbc

08:45 – 09:00

Welcome address

 

 

09:00 – 12:00

Brain tumors in children vs adults - Updates on basic science and clinic

09:00 – 09:45

Gliomas in children

 

Gliomas in adults

09:45 – 10:30

Medulloblastoma in children

 

Medulloblastomas in adults

 

 

10:30 – 11:00

Break with coffee/tea

 

 

11:00 – 12:00

Ependymal tumors in adults and childhood

 

Molecular genetics and classification

 

Clinical view  and treatment (EANO guidelines)

 

 

12:00 – 13:00

Lunch Break

 

 

13:00 – 14:30

Cancer registries: from research to clinical support

 

Chairs: tbc

 

1.  Cancer registries in Sweden from 1958 and onwards –
research, clinic and patient outcome

 

2.  Patient focused registries can improve health care and science

 

3.  The Canton of Zurich Registry 1980-2015

 

4.  The Dutch Brain Tumor registration

 

5.  What is beyond clinical trials ?

 

 

14:30 – 15:00

Break with coffe/tea

 

 

15:00 – 16:30

Update on non-glial CNS tumors

 

Chairs: tbc

15:00 – 15:30

Primary central nervous system lymphoma

15:30 – 16:00

CNS Metastasis: from basic science to clinical trials

16:00 – 16:30

Spinal tumors

16:30 - 17:00

Optimising radiotherapy in non-glial tumors

 

 

START OF EANO MEETING:
16:45 – 18:15

Corporate Symposium (tbc)

   

19.00 – 21.00

Networking – Get together

 

Room:

 

Chairs: tbc

 

09:00 – 09:20

Welcome & Introductions

09:20 – 09:30

TBTC introduction

09:30 – 10:30

In depth Neuro-radiology teaching

 

 

10:30 – 11:00

Coffee Break

 

 

 

Chairs: tbc

11:00 – 11:30

Carers Champion programme

11:30 – 12:00

Swedish – Nordic Caregivers programme  

12:00 – 12:30

UK Family/caregivers weekend

 

 

12:30 – 13:30

Lunch Break

 

 

 

Chairs: tbc

13:30 – 14:00

Person centred care and palliation

14:00 – 14:30

U.S. Family Caregivers programme 

14:30 – 15:00

Quality of Life in adolescents and young adults (AYA) with cancer

 

 

15:00 – 15:30

Coffee Break

 

 

15:30 – 16:30

Managing patient and caregivers expectations

16:30 – 17:00

Different voices of patients and spouses in cases of malignant glioma

17:00 – 17:15

Closing Remarks & Discussion

 

 

START OF EANO MEETING:
19:00 - 21:00 Networking - Get together
  

08:00 – 09:00

Wake up Sessions 1 - Controversies in Non – surgical Treatment

 

Room: tbc

 

Chairs: tbc

 

1.  Proton therapy or Gamma knife or stereotactic linacc

 

2.  When to use PET?

 

3.  Optune when to use and when not?

 

 

08:00 – 09:00

Wake up Session 2 - Controversies in Surgery

 

Room: tbc

 

Chairs: tbc

 

1.  The solitary metastasis: surgery or SRS?

 

2.  Unexpected residual disease: should we go back in before starting radiotherapy?

 

3.  The incidental meningioma: should we operate or should we observe?

 

 

08:00 – 09:00

Wake up session 3 - Controversies in Basic science

 

Room: tbc

 

Chairs: tbc

 

1.  Epigenetic heterogeneity of gliomas at the single cell level

 

2.  Long-non-coding RNAs in brain tumor pathogenesis

 

3.  Genetic drivers of rare brain tumor entities

 

 

09:00 – 10:30

Meet the Expert Session 1 – Update in the management of adult high-grade glioma

 

Room: tbc

 

Chairs: tbc

 

1.  Important markers in the decision making

 

2.  Diagnosis and Treatment

 

3.  Supportive Care in the Short Term and Long Term from a medical and supportive care view

 

4.  What next?

 

 

09:00 – 10:30

Meet the Expert Session 2 – Clinical Psycho-neurooncology

 

Room: tbc

 

Chairs: tbc

 

1.  Hope work is facilitated by the establishment of a helping plan

 

2.  Psychiatric symptoms and emotional distress in cases of brain tumours

 

3.  Endpoints in brain tumor clinical trials and their value in clinical care

 

4.  Rehabilitation of cognitive deficits in brain tumors

 

 

09:00 – 10:30

Meet the Expert Session 3 - Molecular and Cellular Biology of Brain Tumors

 

Room: tbc

 

Chairs: tbc

 

1.  Clonal hierarchy of gliomas

 

2.  Metabolic alterations driving glioma pathogenesis  

 

3.  Molecular and cellular biology of glioma progression

 

 

10:30 – 11:00

Coffee Break

 

 

11:00 - 13:00

Oral Session 1– Basic Science and Pathology

 

Room: tbc

 

Chairs: tbc

 

Key lecture

6 presentations from selected abstracts

 

 

11:00 - 13:00

Oral Session 2 – Non-surgical treatment

 

Room: tbc

 

Chairs: tbc

 

Key lecture

6 presentations from selected abstracts

 

 

11:00 - 13:00

Oral Session 3 – Surgery

 

Room: tbc

 

Chairs: tbc

 

1.  Maximising extent of resection in glioma surgery in clinical trials

 

2.  Is awake craniotomy feasible for children?

 

3.  Endoscopy as an adjunct to glioma surgery: current evidence 

 

4.  Non-invasive surgical approaches 

 

5.  Molecular Imaging for Surgical Planning

 

6.  Glioma Surgery in the Elderly Patient

 

 

11:00 – 13:00

Oral Session 4 – Nursing perspective

 

Room: tbc

 

Chairs: tbc

 

1.  A 12-week interdisciplinary rehabilitation trial in patients with gliomas – a feasibility study

 

2.  How can we best respond to patients who increasingly use alternative medicine

 

3.  Patient reported outcomes of the brain tumour quality registry

 

4.  Milton Marks Family Camp

 

5.  Heterogeneity in QoL in patients before and after brain tumour surgery

 

6.  Ketogenic diet – fact or fiction?

 

 

13:00 – 14:30

Lunch break / Corporate Symposia

 

 

14:30 - 14:45

Opening and Presidential Address

 

 

14:45 – 15:30

Opening Lecture

 

Room:  tbc

 

Chairs: tbc

 

Advancement of Brain Tumor Classification – “From WHO 2016 to cIMPACT-NOW“

 

 

15:15 – 15:30

Coffee Break

 

 

15:30 – 17:00

Plenary Session 1 – Immunogenicity and Immunotherapy

 

Room: tbc

 

Chairs: tbc

 

1.  Preclinical aspects of immunogenicity in gliomas

 

2.  Clinical aspects on immunotherapy targets in glioma

 

3.  CAR T-cell therapy of brain tumours: status quo and quo vadis?

 

4.  Practice aspects for todays neuro-oncology

 

 

15:30 – 17:00

Plenary Session 2 – Nurse session

 

Room: tbc

 

Chairs: tbc

 

1.  Biomarkers for daily clinical use

 

2.  Role of intraoperative neurophysiology

 

3.  Minimising treatment toxicity

 

4.  Interdisciplinary neurorehabilitation

 

 

15:30 – 17:00

Plenary Session 3 - Pediatric Neuro-Oncology

 

Room: tbc

 

Chairs: tbc

 

1.  Neuropathology and classification of pediatric brain tumors 

 

2.  Metylation classification in pediatric brain tumors

 

3.  International pediatric brain tumor trials - a role model for adult neurooncology

 

4. Diffuse midline gliomas

 

 

17:00 – 18:00

Poster viewing session I (Poster walk) with authors snacks and drinks

 

1.  Glioma – clinical aspects

 

2.  Glioma – preclinical aspects

 

3.  Other – clinical aspects

 

4.  Other – preclinical

 

5.  Nursing perspective

 

 

18:00 - 19:30

Corporate symposium

 

Room: tbc

08:00 - 09:00

Wake up Session 4 – Novel approaches of molecular tumor classification

 

Room: tbc

 

Chairs: tbc

 

1.  Novel approaches based on DNA methylation and epigenetic profiles

 

2.  Novel approaches based on Nanopore Sequencing

 

3.  Novel radiogenomic approaches for glioma diagnostics

 

 

08:00 – 09:00

Wake up session 5 – Trial design and Outome measures

 

Room: tbc

 

Chairs: tbc

 

1.  Molecularly informed trial designs (umbrella/basket trials)

 

2.  Patient centered outcome

 

3.  Near - randomised studies - a valuable tool in neuro-surgery studies

 

 

08:00 – 09:00

Wake up session 6 – Nursing perspective

 

Room: tbc

 

Chairs: tbc

 

1.  Early palliative care 

 

2.  Neurocognitive screening and management

 

3.  Mood and behavior disorders

 

 

09:00 – 10:30

Meet the Expert Session 4 –  CNS Metastasis: from basic science to clinical trials

 

Room: tbc

 

Chairs: tbc

 

1. CNS metastasis: molecular pathways to clinical trials

 

2. Tumor invasion

 

3. Molecular divergence how to approach?

 

4. How to optimize imaging for the evaluation of responses to treatments?

 

 

09:00 – 10:30

Meet the Expert Session 5 –  Update in the management of meningioma and benign tumours

 

Room: tbc

 

Chairs: tbc

 

1.  Molecular markers in the decision making?

 

2.  Diagnosis and Treatment

 

3.  Supportive Care in the Short Term and Long Term

 

4.  What next?

 

 

10:30 – 11:00

Coffee Break

 

 

11:00 - 13:00

Oral Session 5 – Molecular Genetics and Epigenetics

 

Room: tbc

 

Chairs: tbc

 

1.  Key lecture

2.  6 presentations from selected abstracts

 

 

11:00 - 13:00

Oral Session 6 –  Supportive care

 

Room: tbc

 

Chairs: tbc

 

1.  Key lecture
2.  6 presentations from selected abstracts

 

11:00 - 13:00

Oral Session 7 - Pediatric Brain Tumors

 

Room: tbc

 

Chairs: tbc

 

1.  Key lecture

2.  6 presentations from selected abstracts

 

 

13:00 – 14:30

Lunch break / Corporate Symposia

 

 

14:30 – 15:30

Plenary Session 4 –  Management of adult and pediatric Low Grade Gliomas

 

Room: tbc

 

Chairs: tbc

 

1.  Update on molecular pathology in adults

 

2.  Treatment – high risk or low risk adult  patients?

 

3.  Surgical treatment

 

4.  Therapy in children

 

 

14:30 – 15:30

Plenary Session 5 – Treatment Resistance

 

Room: tbc

 

Chairs: tbc

 

1.  Genetic/Epigenetic mechanisms

 

2.  Cellular Mechanisms/stem cells/DNA damage response

 

3.  Tumor microtubes and therapy resistance of gliomas  

 

4.  Clinical perspective?

 

 

14:30 – 15:30

Plenary Session 6 – Basic immunology

 

Room: tbc

 

Chairs: tbc

 

1.  Biomarker development for decision-making 

 

2.  Preclinical models

 

3.  Tumor derived T-cell ligandome

 

4.  Translational immunology

 

 

15:30 – 17:00

Better and knowledgeable patients – better professionals – better decisions – better outcomes

 

Room: tbc

 

Chairs: tbc

 

1. The preferences of the patients and spouses

 

2. The health care perspective and shared decision making

3. Do I want to know it all?

 

4. When conflict of interest arise – Who is the patient advocate

 

 

17:00 – 18:00

Poster viewing session 2 with authors (Poster walk) – snacks and drinks

 

1.  Glioma – clinical aspects

 

2.  Glioma – preclinical aspects

 

3.  Other – clinical aspects

 

4.  Other – preclinical

 

5.  Nursing perspective

 

 

08:30 – 09:30

EANO General assembly

 

Room: tbc

 

 

09:30 – 10:30

Ethical issues

 

Room: tbc

 

Chairs: tbc

 

1.  When to reject treatment and when to stop treatment?

 

2.  Euthanasia in brain tumour patients

 

3.  Quality of life – Quality of death

 

 

09:30 – 10:30

Experimental models

 

Room: tbc

 

Chairs: tbc

 

1.  Preclinical models and experimental therapy

 

2.  Translational applications of adult stem cell-derived organoids

 

3.  PDX for drug development

 

 

10:30 – 11:00

EORTC Brain Tumor studies

 

Room: tbc

 

 

10:30 – 11:00

Coffee Break

 

 

11:00 – 12:30

EANO Youngster Session “Perspectives in Neuro-Oncology”

 

Room: tbc

 

Chairs: tbc

 

Key lecture

 

1.   How EANO can impact your career development

 

2.   Basic science as a driver of Neuro-Oncology research

 

3.   Dos and don’t s in clinical trial design

 

4.   Making science count: which data impact clinical management

 

 

11.00 – 12.30 

Oral Session 8 – General clinical neurooncology

 

Room: tbc

 

Chairs: tbc

 

1.  Key lecture

2.  6 presentations from selected abstracts

 

 

12:30 – 13.00

Next-generation glioma treatment by targeting tumor specific pathways

 

Room: tbc

 

Chairs: tbc

 

 

13:00

Awards & Closing remarks – from president to president

 

Room: tbc

 

 

Information will follow soon.